IASLC Launches Beta Version of VIKTOR

Smoking Cessation in Lung Cancer Screening: The Latest Randomized Controlled Trial Evidence

IASLC, LCRF Request Proposals for New Research Grant

IASLC Announces Partnerships to Spur Oncogene-Driven Lung Cancer Research, Address Global Challenges in Conquering Thoracic Cancers

Renowned Researcher Fred Hirsch Delivers 2022 Heine H. Hansen Award Lecture

Pathology Researcher Keith Kerr Receives 2025 Heine H. Hansen Award

Journal of Thoracic Oncology’s Impact Factor Rises Again; JTO Clinical and Research Reports Receives First Impact Factor

Researcher Reveals How Air Pollution May Cause Lung Cancer

In Case You Missed It: IASLC Launches New Education Center

Tobacco Control Impacts Everyone in Respiratory Medicine, JTO CRR Editor Says

IASLC Launches Global Member Survey on Diversity, Equity, and Inclusion

… from systemic disparities that impact (i) access to research and funding for those engaged in any research on lung cancer and other thoracic malignancies and …

Can pCR Be an Early Clinical Trial Endpoint? Initiative Aims to Answer That Question

… at correlating with event-free and overall survival. Researchers have a digital platform and AI algorithm to … with large trials have agreed to contribute their data.” Researchers will be looking to see if pCR leads to long-term …